Optimal antiplatelet strategy in Asian patients presenting with acute coronary syndrome

We have read an article written by Shuning Zhang and his colleagues [ [1] Zhang R. Wang W. Sawhney J.P.S. et al. Antithrombotic management and long-term outcomes following percutaneous coronary intervention for acute coronary syndrome in Asia. Int. J. Cardiol. 2020; 310: 16-22https://doi.org/10.1016/j.ijcard.2020.01.008 Abstract Full Text Full Text PDF PubMed Scopus (4) Google Scholar ]. This paper revealed that most of the patients in Asia who presented with acute coronary syndrome (ACS) undergo percutaneous coronary intervention (PCI), many of them were on long-term dual antiplatelet (DAPT) and there were increased bleeding events.